Referenser till artikeln " Kronisk smärta och dysbios - en funktionsmedicinsk översikt"

1) Rubin, R. Scientist says FDA system "broken". USA Today, 2004-11-19. http://www.usatoday.com/money/industries/health/drugs/2004-11-18-vioxx_x.htm
2) Mukherjee D., Nissen S.E., Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286(8):954-9.
3) Ray W.A., Stein C.M., Daugherty J.R., Hall K., Arbogast P.G., Griffin M.R. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.
Lancet 2002;360:1071-3.
4) Topol E.J. Arthritis medicines and cardiovascular events – "house of coxibs". JAMA, Jan. 19, 2005;293(3):366-8.
5) Dwyer J.H., Allayee H., Dwyer K.M. et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med, Jan. 1, 2004;350(1):29-37.
6) Vasquez A. Integrative Orthopedics: The Art of Creating Wellness While Effectively Managing Acute and Chronic Musculoskeletal Disorders.
7) Fain J.N., Madan A.K., Hiler M.L., et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology May 2004;145(5):2273-82.
8) Petersen A.M., Pedersen B.K. The anti-inflammatory effect of exercise. J Appl Physiol April 2005;98(4):1154-62.
9) Brady, D. Functional Medicine. Dynamic Chiropractic, 1999;17:08.
10) Galland, L., Lafferty, H. Gastrointestinal dysregulation: connections to chronic disease. The Institute for Functional Medicine, 2008.
11) Weyand CM, Goronzy JJ. Clinically silent infections in patients with oligoarthritis: results of a prospective study." Ann Rheum Dis. 1992;51:2,253-8.
12) Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Groh A, Uksila J, Granfors K, Braun J, Sieper J. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2001;60:4,337-43.
13) Vasquez A. Reducing Pain and Inflammation Naturally. Part 6: Nutritional and Botanical Treatments Against "Silent Infections" and Gastrointestinal Dysbiosis, Commonly Overlooked Causes of Neuromusculoskeletal Inflammation and Chronic Health Problems. Nutritional Perspectives: Journal of the Council on Nutrition of the American Chiropractic Association. 2006.
14) H Mielants, M Devos, C Cuvelier, EM Veys. The role of GUT inflammation in the pathogenesis of spondyloarthropathies. Acta Clinica Belgica 51: 5 (OCT 1996):340-349.
15) Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. Med Microbiol. 2000 Apr;49(4):305-11.
16) Wilson C, Rashid T, Tiwana H, Beyan H, Hughes L, et al. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis. J Rheumatol. 2003 May;30(5):972-8.
17) E Markerhermann, T Hohler. Pathogenesis of human leukocyte antigen B27-positive arthritis: Information from clinical materials. Rheumatic Disease Clinics of North America 24: 4(NOV 1998):865.
18) F Dekeyser, D Elewaut, M Devos, K Devlam, C Cuvelier, H Mielants, EM Veys. Bowel inflammation and the spondyloarthropathies. Rheumatic Disease Clinics of North America. 24: 4(NOV 1998):785.
19) Domínguez-López ML, Cancino-Díaz ME, Jiménez-Zamudio L, et al.
Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol. 2000 Jun;27(6):1453-60.
20) Rashid T, Ebringer A. Ankylosing spondylitis is linked to Klebsiella--the evidence. Clin Rheumatol. 2007 Jun;26(6):858-64. Epub 2006 Dec 21.
21) Mercola, J. Dr. Brown's Modified Protocol For Using Antibiotics In The Treatment Of Rheumatic Diseases. Presented at the 32nd International Congress of the Great Lakes College of Clinical Medicine Baltimore, Maryland, September 25, 1999. http://www.rheumatic.org/protocol.htm
22) Ebringer A., Wilson C. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clinical Rheumatology 1996; 15 Suppl. 1, 61-65.
23) Gottschall E. Breaking the Vicious Cycle: Intestinal Health Through Diet. Kirkton Press; Rev Edition (August 1, 1994).
24) Sortino MA, Cronin MJ, Wise PM. Relaxin stimulates prolactin secretion from anterior pituitary cells. Endocrinology. 1989 Apr;124(4):2013-5.
25) Tabassum Naqvi, Trang T Duong, Gihan Hashem. Relaxin's induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants. Arthritis Res Ther. 2005; 7(1):1–11.
26) St. Clair W., Pisetsky D.S., Haynes B.F. (eds). Rheumatoid Arthritis. Lippincott Williams & Wilkins, 2004.
27) Vasquez A. Multifocal Dysbiosis: Pathophysiology, Relevance for Inflammatory and Autoimmune Diseases, and Treatment With Nutritional and Botanical Interventions. Naturopathy Digest, 2006.